BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36467028)

  • 1. Distinct common signatures of gut microbiota associated with damp-heat syndrome in patients with different chronic liver diseases.
    Pan Y; Guo J; Hu N; Xun Y; Zhang B; Feng Q; Chen S; Li X; Liu Q; Hu Y; Zhao Y
    Front Pharmacol; 2022; 13():1027628. PubMed ID: 36467028
    [No Abstract]   [Full Text] [Related]  

  • 2. Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
    Wang J; Wang Y; Zhang X; Liu J; Zhang Q; Zhao Y; Peng J; Feng Q; Dai J; Sun S; Zhao Y; Zhao L; Zhang Y; Hu Y; Zhang M
    Front Microbiol; 2017; 8():2222. PubMed ID: 29180991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Analysis of Clinical and Medication Information between Chronic Hepatitis B Patients with Damp Heat Syndrome and Spleen Deficiency Syndrome.
    Liu QH; Zhang BB; Xu L; Shen XP; Hai YM; Hu YY; Zhao Y
    Evid Based Complement Alternat Med; 2020; 2020():8846637. PubMed ID: 33424996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.
    Zhang YL; Cai LT; Qi JY; Lin YZ; Dai YC; Jiao N; Chen YL; Zheng L; Wang BB; Zhu LX; Tang ZP; Zhu RX
    World J Gastroenterol; 2019 Jul; 25(25):3242-3255. PubMed ID: 31333315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of traditional Chinese medicine treatment on chronic unpredictable mild stress-induced depression-like behaviors: intestinal microbiota and gut microbiome function.
    Qu W; Liu S; Zhang W; Zhu H; Tao Q; Wang H; Yan H
    Food Funct; 2019 Sep; 10(9):5886-5897. PubMed ID: 31464319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
    Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
    Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divergent impacts on the gut microbiome and host metabolism induced by traditional Chinese Medicine with Cold or Hot properties in mice.
    Li B; Tao X; Sheng L; Li Y; Zheng N; Li H
    Chin Med; 2022 Dec; 17(1):144. PubMed ID: 36572936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of Correlation between Intestinal Microbiota and Traditional Chinese Medicine Syndrome of Patients with Colon Cancer.
    Tuo LY; Zhang ZR; Xin H; Chu X; Xu W
    Evid Based Complement Alternat Med; 2022; 2022():2989456. PubMed ID: 35859998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease.
    Delik A; Dinçer S; Ülger Y; Akkız H; Karaoğullarından Ü
    Gene; 2022 Jul; 833():146587. PubMed ID: 35598686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCM syndrome differentiation in colorectal cancer patients assisted by differences in gut microbiota: An exploratory study.
    Ming-Bin G; Ya-Nan W; Yong-Ting X; Min Z; Hao T; Lian-Ping Q; Feng G
    Heliyon; 2023 Nov; 9(11):e21057. PubMed ID: 37928040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.
    Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L
    Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular classification and clinical diagnosis of acute-on-chronic liver failure patients by serum metabolomics.
    Yu M; Zhou C; Tian D; Jia HM; Li ZQ; Yang C; Ba YM; Wu HK; Zou ZM
    J Pharm Biomed Anal; 2021 May; 198():114004. PubMed ID: 33721610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota alterations are associated with functional outcomes in patients of acute ischemic stroke with non-alcoholic fatty liver disease.
    Yu G; Chen Q; Chen J; Liao X; Xie H; Zhao Y; Liu J; Sun J; Chen S
    Front Neurosci; 2023; 17():1327499. PubMed ID: 38178834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on the differences of gut microbiota composition between phlegm-dampness syndrome and qi-yin deficiency syndrome in patients with metabolic syndrome.
    Shang H; Zhang L; Xiao T; Zhang L; Ruan J; Zhang Q; Liu K; Yu Z; Ni Y; Wang B
    Front Endocrinol (Lausanne); 2022; 13():1063579. PubMed ID: 36440222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determining the protective effects of Yin-Chen-Hao Tang against acute liver injury induced by carbon tetrachloride using 16S rRNA gene sequencing and LC/MS-based metabolomics.
    Liu F; Sun Z; Hu P; Tian Q; Xu Z; Li Z; Tian X; Chen M; Huang C
    J Pharm Biomed Anal; 2019 Sep; 174():567-577. PubMed ID: 31261038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota.
    Han R; Qiu H; Zhong J; Zheng N; Li B; Hong Y; Ma J; Wu G; Chen L; Sheng L; Li H
    Phytomedicine; 2021 May; 85():153544. PubMed ID: 33773192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of plasma proteome from cases of the different traditional Chinese medicine syndromes in patients with chronic hepatitis B.
    Liu Y; Liu P; Dai R; Wang J; Zheng Y; Shen J; Guo F; Wang L; Li H; Wei M
    J Pharm Biomed Anal; 2012 Feb; 59():173-8. PubMed ID: 22030074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Monounsaturated Triacylglycerol Predicts Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease and Chronic Hepatitis B.
    Yang RX; Hu CX; Sun WL; Pan Q; Shen F; Yang Z; Su Q; Xu GW; Fan JG
    Sci Rep; 2017 Sep; 7(1):10517. PubMed ID: 28874844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.